Absolute Binding Free Energy Calculations for Highly Flexible Protein MDM2 and Its Inhibitors

被引:17
|
作者
Singh, Nidhi [1 ,2 ]
Li, Wenjin [1 ]
机构
[1] Shenzhen Univ, Inst Adv Study, Shenzhen 518060, Peoples R China
[2] Shenzhen Univ, Coll Phys & Optoelect Engn, Shenzhen 518060, Peoples R China
基金
中国国家自然科学基金;
关键词
binding free energy; free energy perturbation; molecular dynamics; MDM2; GENERAL FORCE-FIELD; MOLECULAR-DYNAMICS; P53-MDM2; INTERACTION; LEAD OPTIMIZATION; T4; LYSOZYME; DISCOVERY; DESIGN; POTENT; P53; ANTAGONISTS;
D O I
10.3390/ijms21134765
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Reliable prediction of binding affinities for ligand-receptor complex has been the primary goal of a structure-based drug design process. In this respect, alchemical methods are evolving as a popular choice to predict the binding affinities for biomolecular complexes. However, the highly flexible protein-ligand systems pose a challenge to the accuracy of binding free energy calculations mostly due to insufficient sampling. Herein, integrated computational protocol combining free energy perturbation based absolute binding free energy calculation with free energy landscape method was proposed for improved prediction of binding free energy for flexible protein-ligand complexes. The proposed method is applied to the dataset of various classes of p53-MDM2 (murine double minute 2) inhibitors. The absolute binding free energy calculations for MDMX (murine double minute X) resulted in a mean absolute error value of 0.816 kcal/mol while it is 3.08 kcal/mol for MDM2, a highly flexible protein compared to MDMX. With the integration of the free energy landscape method, the mean absolute error for MDM2 is improved to 1.95 kcal/mol.
引用
收藏
页码:1 / 15
页数:16
相关论文
共 50 条
  • [31] BAT2: an Open-Source Tool for Flexible, Automated, and Low Cost Absolute Binding Free Energy Calculations
    Heinzelmann, Germano
    Huggins, David J.
    Gilson, Michael K.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2024, 20 (15) : 6518 - 6530
  • [32] CHARMM-GUI Ligand Binder for Absolute Binding Free Energy Calculations and Its Application
    Jo, Sunhwan
    Jiang, Wei
    Lee, Hui Sun
    Roux, Benoit
    Im, Wonpil
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (01) : 267 - 277
  • [33] Quinone inhibitors docking structures in its oxidoreductase and binding free energy calculations.
    Zhou, ZG
    Moe, OA
    Madura, JD
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U399 - U399
  • [34] Identification of the Flexible Regions Differentiating Ligand-Binding Affinity for Mdm2 and MdmX
    Su, Zheng
    Cheng, Xiyao
    Qin, Lingyun
    Rong, Rong
    Huang, Yongqi
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 31A - 31A
  • [35] Absolute Binding Affinity Calculation for MDM2 Bound to a Disordered Fragment of P53
    Zhan, Yingqian
    Ytreberg, F. Marty
    BIOPHYSICAL JOURNAL, 2013, 104 (02) : 234A - 234A
  • [36] Small-Molecule Inhibitors of the MDM2-p53 Protein-Protein Interaction (MDM2 Inhibitors) in Clinical Trials for Cancer Treatment
    Zhao, Yujun
    Aguilar, Angelo
    Bernard, Denzil
    Wang, Shaomeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1038 - 1052
  • [37] Absolute Binding Free Energy Calculations of Sparsomycin Analogs to the Bacterial Ribosome
    Ge, Xiaoxia
    Roux, Benoit
    JOURNAL OF PHYSICAL CHEMISTRY B, 2010, 114 (29): : 9525 - 9539
  • [38] Predictions of Ligand Selectivity from Absolute Binding Free Energy Calculations
    Aldeghi, Matteo
    Heifetz, Alexander
    Bodkin, Michael J.
    Knapp, Stefan
    Biggin, Philip C.
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2017, 139 (02) : 946 - 957
  • [39] Ligand Binding Mode Prediction by Docking: Mdm2/Mdmx Inhibitors as a Case Study
    Bharatham, Nagakumar
    Bharatham, Kavitha
    Shelat, Anang A.
    Bashford, Donald
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2014, 54 (02) : 648 - 659
  • [40] AMPLIFICATION OF THE MDM2 GENE IN HUMAN BREAST-CANCER AND ITS ASSOCIATION WITH MDM2 AND P53 PROTEIN STATUS
    MCCANN, AH
    KIRLEY, A
    CARNEY, DN
    CORBALLY, N
    MAGEE, HM
    KEATING, G
    DERVAN, PA
    BRITISH JOURNAL OF CANCER, 1995, 71 (05) : 981 - 985